<- Go Home
Futura Medical plc
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Market Cap
GBP 3.2M
Volume
2.1M
Cash and Equivalents
GBP 3.4M
EBITDA
-GBP 9.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 1.2M
Profit Margin
73.08%
52 Week High
GBP 0.15
52 Week Low
GBP 0.00
Dividend
N/A
Price / Book Value
1.16
Price / Earnings
-0.20
Price / Tangible Book Value
1.16
Enterprise Value
-GBP 157.8K
Enterprise Value / EBITDA
0.02
Operating Income
-GBP 9.1M
Return on Equity
154.16%
Return on Assets
-60.53
Cash and Short Term Investments
GBP 3.4M
Debt
N/A
Equity
GBP 2.8M
Revenue
GBP 1.7M
Unlevered FCF
-GBP 4.9M
Sector
Pharmaceuticals
Category
N/A